REDUCE-IT
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia D. L. Bhatt, et al. for the REDUCE-IT Investigators N Engl J
Continue readingCardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia D. L. Bhatt, et al. for the REDUCE-IT Investigators N Engl J
Continue readingAcetazolamide in Acute Decompensated Heart Failure with Volume Overload. Mullens W, Dauw J, Martens P, et al. for the ADVOR
Continue readingThe neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Adamstein NH, MacFadyen JG, Rose LM, Glynn
Continue readingAngiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Pfeffer MA, Claggett B, Lewis EF, et al.; PARADISE-MI Investigators and Committees. N
Continue readingComplete Revascularization with Multivessel PCI for Myocardial Infarction Mehta SR, Wood DA, Storey RF, et al. N Engl J Med.
Continue readingTrial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. Kirchhof P, Camm AJ, Goette A, et al.; EAST-AFNET 4
Continue readingEmpagliflozin in Heart Failure with a Preserved Ejection Fraction. Anker SD, Butler J, Filippatos G, et al.; EMPEROR-Preserved Trial Investigators.
Continue readingAntithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. Lopes RD, Heizer G, Aronson R, et al; AUGUSTUS
Continue readingAngiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. Velazquez E.J., Morrow D. A., DeVore A.D., et al. for the PIONEER-HF Investigators
Continue readingDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction McMurray JJV, Solomon SD, Inzucchi SE, et al.; DAPA-HF Trial
Continue reading